The notices it replaced
- Reissues: PAR-19-368 Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
- 2 steps back: PAR-18-062 Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
- 3 steps back: PAR-16-234 Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)
- 4 steps back: PAR-13-080 Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)
- 5 steps back: PAR-10-018 Accelerating the Pace of Drug Abuse Research Using Existing Epidemiology, Prevention, and Treatment Research Data (R01)
Replaced by RFA-DA-26-055.
Who won it before
125 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $61,118,662 in first-year total cost, median $450,712.
Most frequent study sections
- Special Emphasis Panel[ZRG1 PSE-W (55)]42
- Special Emphasis Panel[ZRG1 PSE-P (55)]20
- Special Emphasis Panel[ZDA1 LXF-E (M1)]12
- Special Emphasis Panel[ZDA1 LXF-E (J1)]9
- Special Emphasis Panel[ZDA1 LXF-C (04)]6
Most frequent institutions
- UNIVERSITY OF MICHIGAN AT ANN ARBOR9
- JOHNS HOPKINS UNIVERSITY7
- YALE UNIVERSITY5
- COLUMBIA UNIVERSITY HEALTH SCIENCES4
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE4
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Optimizing methadone treatment strategies for opioid use disorder in the era of fentanyl1R01DA062186-01A1 | BEAUDOIN, FRANCESCAWIGHTMAN, RACHELZULLO, ANDREW REIS | BROWN UNIVERSITY, RI | $915,478 | ZDA1 |
| 2025 | Advancing patient-centered research using meta-analysis of individual patient data to identify clinically significant trajectories of PTSD/SUD and recovery outcomes1R01DA061338-01A1 | HIEN, DENISE AIMEEMORGAN-LOPEZ, ANTONIO A | RUTGERS, THE STATE UNIV OF N.J., NJ | $882,816 | ZDA1 |
| 2025 | Neuromarkers for craving and drug use1R01DA063043-01 | KOBER, HEDYWAGER, TOR D. | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $800,617 | ZDA1 |
| 2025 | Examining the Effects of ADHD Medications on Substance-Related Morbidity and Mortality Among Young People1R01DA062181-01A1 | D'ONOFRIO, BRIAN M | TRUSTEES OF INDIANA UNIVERSITY, IN | $779,831 | ZDA1 |
| 2025 | The Impact of Cannabis Use Disorder and its Treatment on Opioid-related Health Consequences: A Longitudinal Study of VA Patients1R01DA064130-01 | LIVNE, OFIRMANNES, ZACHARY L | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $744,875 | ZDA1 |
| 2025 | Characterizing Complex OUD Care Trajectories and Outcomes following Acute Service Utilization: A Population-Based Data Linkage Study1R01DA061367-01A1 | KRAWCZYK, NOAWILLIAMS, ARTHUR R | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $722,876 | ZDA1 |
| 2025 | Vulnerability to Substance Use: Transitions and Trajectories in ABCD Youth with Validation Using Longitudinal Twin Family Samples1R01DA063061-01 | FRIEDMAN, NAOMI P.LUCIANA, MONICAMADDEN, PAMELA ANNMAES, HERMINE HWILSON, SYLIA | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $720,763 | ZDA1 |
| 2025 | Longitudinal pathways between adolescent social media use and substance use: Informing evidence-based guidance1R01DA064134-01 | NAGATA, JASON M | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $703,457 | ZDA1 |
| 2024 | The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy2R01DA049822-05 | BATEMAN, BRIAN THOMASHUYBRECHTS, KRISTA F | BRIGHAM AND WOMEN'S HOSPITAL, MA | $839,898 | ZDA1 |
| 2024 | Telemedicine for Treatment of Opioid Use Disorder2R01DA048533-05 | HUSKAMP, HAIDEN A.MEHROTRA, ATEEV | HARVARD MEDICAL SCHOOL, MA | $792,888 | ZDA1 |
| 2024 | Network-based study design, statistical, and modeling solutions for HIV among populations that use illicit substances: Informing interventions and policy in real-world settings using existing data1R01DA058994-01A1 | BUCHANAN, ASHLEY LYNN | UNIVERSITY OF RHODE ISLAND, RI | $771,618 | ZDA1 |
| 2024 | Disparities in early childhood health outcomes following prenatal opioid exposure and protective health system factors: a population perspective1R01DA062152-01 | LEYENAAR, JOANNA | DARTMOUTH-HITCHCOCK CLINIC, NH | $749,803 | ZDA1 |
| 2024 | Universal HCV screening in pregnancy: Examining testing uptake and HCV care1R01DA060499-01A1 | KAPADIA, SHASHI | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $707,647 | ZDA1 |
| 2024 | TRANSFORM - Transforming the evidence base on estimating prevalence of opioid use disorder and expanded access to interventions to prevent drug related deaths: an international data linkage study1R01DA059822-01A1 | DEGENHARDT, LOUISAHICKMAN, MATTMARTIN, NATASHA | UNIVERSITY OF NEW SOUTH WALES | $688,653 | ZDA1 |
| 2024 | ENIGMA- Addiction: Pooling of Existing Datasets to Identify Brain and Genetic Correlates of Addiction, Next Steps2R01DA047119-06A1 | GARAVAN, HUGH P. | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $688,498 | ZDA1 |
| 2024 | Establishing if Music Engagement is a Protective Factor in Adolescent Substance Use Using Existing Longitudinal, Genetic, and Environmental Datasets1R01DA059804-01A1 | GUSTAVSON, DANIEL | UNIVERSITY OF COLORADO, CO | $666,519 | ZDA1 |
| 2024 | Leveraging harmonized data to improve external validity and efficiency of clinical trials for treating opioid use disorder1R01DA059824-01A1 | MILES, CALEB HILLIARDRUDOLPH, KARA ELIZABETH | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $564,326 | ZDA1 |
| 2024 | Novel Methods to Inform mHealth Interventions for Substance Use1R01DA058996-01A1 | ERTEFAIE, ASHKANNAHUM-SHANI, INBAL BILLIE | UNIVERSITY OF ROCHESTER, NY | $505,617 | ZDA1 |
| 2024 | Trajectories of Prescription Nonmedical Drug Misuse2R01DA031160-10A1 | MCCABE, SEAN ESTEBAN | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $431,941 | ZDA1 |
| 2024 | Health Effects of E-cigarette Use on Brain Functions and Cognitive Development among Adolescents: A US Population-Based Study1R01DA060466-01 | BENOWITZ, NEAL LDAI, HONGYING DAISY | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $393,141 | ZDA1 |
| 2024 | Direct and Indirect Effects of Disasters on Drug-Related Outcomes1R01DA059826-01A1 | VUOLO, MICHAEL C | OHIO STATE UNIVERSITY, OH | $388,857 | ZDA1 |
| 2024 | Employment Insecurity and Substance Use in U.S. Adults1R01DA061309-01 | LEE, JUNGEUN OLIVIA | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $373,485 | ZDA1 |
| 2023 | Understanding the short- and long-term effects of the COVID-19 pandemic on the overdose crisis1R01DA058991-01 | CERDA, MAGDALENAFRIEDMAN, SAMUEL R | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $1,038,834 | ZDA1 |
| 2023 | Researching Effective Strategies to Prevent Opioid Death (RESPOND)2R01DA046527-06A1 | LINAS, BENJAMIN P. | BOSTON MEDICAL CENTER, MA | $895,767 | ZDA1 |
| 2023 | Impact of prescription stimulants on the drug overdose epidemic1R01DA058315-01 | MORAN, LAUREN V | MCLEAN HOSPITAL, MA | $792,922 | ZDA1 |
| 2023 | Estimating Mediation and Moderation Effects in HIV Care Continuum Intervention Trials for People who Use Drugs1R01DA058311-01 | PITPITAN, EILEEN VIRTUSIO | SAN DIEGO STATE UNIVERSITY, CA | $742,131 | ZDA1 |
| 2023 | Impact of Recreational and Medical Marijuana legalization on cannabis use disorders, serious mental illness, and mortality outcomes among Medicaid enrolled youth1R01DA058303-01 | FONTANELLA, CYNTHIA ANNHAMMOND, CHRISTOPHER J. | RESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH | $739,431 | ZDA1 |
| 2023 | Promoting Rapid Uptake of Multilevel Latent Class Modeling via Best Practices: Investigating Heterogeneity in Daily Substance Use Patterns1R01DA057588-01A1 | LANZA, STEPHANIE T | PENNSYLVANIA STATE UNIVERSITY, THE, PA | $733,675 | ZDA1 |
| 2023 | The OUD Cascade of Care and Critical Outcomes: Longitudinal Linkage with Opioid Use1R01DA059042-01 | WILLIAMS, ARTHUR R | NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY | $710,671 | ZDA1 |
| 2023 | A Neuroecological Approach to Examining the Effects of Early Life Adversity on Adolescent Drug Use Vulnerabilities Using the ABCD Dataset1R01DA058334-01A1 | OSHRI, ASSAF | UNIVERSITY OF GEORGIA, GA | $624,952 | ZDA1 |
| 2023 | Discrimination and Racial Inequalities in Drug Use in U.S. Adults: Associations and Mechanisms1R01DA058992-01 | DAI, HONGYING DAISYLEVENTHAL, ADAM MATTHEW | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $385,010 | ZDA1 |
| 2023 | Trauma, Substance Use, and Incarceration Over the Lifecourse: Identifying Social Supports to Promote Resiliency in a US National Cohort Study1R01DA059036-01 | TAM, CHRISTINA | PUBLIC HEALTH INSTITUTE, CA | $380,475 | ZDA1 |
| 2023 | Assessing real-world evidence of the effects of opioid analgesic tapering on substance-related problems1R01DA059026-01 | QUINN, PATRICK DONOVAN | TRUSTEES OF INDIANA UNIVERSITY, IN | $373,987 | ZDA1 |
| 2023 | Longitudinal Changes in Prescription Drug Misuse and Polysubstance Use in Adolescents and Young Adults2R01DA043691-04A1 · under PAR-19-368 | SCHEPIS, TY STEPHEN | TEXAS STATE UNIVERSITY, TX | $327,825 | SSPB |
| 2022 | Predict to Prevent: Dynamic Spatiotemporal Analyses of Opioid Overdose to Guide Pre-Emptive Public Health Responses1R01DA054267-01A1 · under PAR-19-368 | BAUER, CICISTOPKA, THOMAS J | TUFTS UNIVERSITY BOSTON, MA | $760,041 | CIHB |
| 2022 | Role of disability and pain in opioid overdose: mechanism and risk mitigation1R01DA053243-01A1 · under PAR-19-368 | RUDOLPH, KARA ELIZABETH | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $738,149 | BGES |
| 2022 | Leveraging data synthesis to identify optimal and robust strategies for HIV elimination among substance-using MSM1R01DA055502-01 · under PAR-19-368 | JANULIS, PATRICK FRANCIS | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $731,907 | ZRG1 |
| 2022 | Improving MOUD Access, Opioid-Related Outcomes and Equity Among Medicare Beneficiaries with Disability1R01DA057568-01 | CRYSTAL, STEPHEN | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $714,642 | ZDA1 |
| 2022 | Impact of Medicare Part D opioid safety policies on disabled beneficiaries before and during the COVID-19 pandemic1R01DA055131-01 · under PAR-19-368 | WEN, HEFEI | HARVARD PILGRIM HEALTH CARE, INC., MA | $701,067 | ODHS |
| 2022 | Evaluating Policy Interventions to Decrease Excessive and Risky Perioperative Opioid Prescribing1R01DA057284-01 | CHUA, KAO-PINGWALJEE, JENNIFER FILIP | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $680,634 | ZDA1 |
| 2022 | Insurance-related barriers to medications for opioid use disorder in private and Medicaid plans1R01DA056438-01 · under PAR-19-368 | CHUA, KAO-PINGNGUYEN, THUY DIEU | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $676,084 | ODHS |
| 2022 | Identifying Disparities in the Cascade of Care for Medicaid-Enrolled Youth with Opioid Use Disorder1R01DA057566-01 | HADLAND, SCOTT EVANWILLIAMS, ARTHUR R | MASSACHUSETTS GENERAL HOSPITAL, MA | $597,957 | ZDA1 |
| 2022 | Interpretable Deep Forecasting of Hazardous Substance Use during High School1R01DA057567-01 | POHL, KILIAN MARIATAPERT, SUSAN F | STANFORD UNIVERSITY, CA | $498,860 | ZDA1 |
| 2022 | An Examination of the Joint Contributions of Socioeconomic Disadvantage, Genetics, and COVID-19 on the Development of Delay Discounting and Substance Use Across Adolescence1R01DA057552-01 | FELTON, JULIA WMAHER, BRION SRABINOWITZ, JILL ALEXANDRA | JOHNS HOPKINS UNIVERSITY, MD | $434,628 | ZDA1 |
| 2022 | Short-term Outcome of Stimulant Use Disorder Treatment Trials1R01DA054700-01A1 · under PAR-19-368 | MOJTABAI, RAMIN | JOHNS HOPKINS UNIVERSITY, MD | $409,375 | IPTA |
| 2022 | Covid-19 pandemic and changes in the prevalence, patterns, and trajectories of substance use and related health risk outcomes among young adults in WA State1R01DA057705-01 | GUTTMANNOVA, KATARINA | UNIVERSITY OF WASHINGTON, WA | $369,313 | ZDA1 |
| 2022 | The Role of Behavior Therapy Combined with Buprenorphine for the Treatment of Opioid Use Disorder1R01DA054113-01A1 · under PAR-19-368 | MCHUGH, REBECCA KATHRYN | MCLEAN HOSPITAL, MA | $350,550 | IPTA |
| 2022 | Treatment Effect Heterogeneity in Psychosocial Treatments for Substance Use Disorders1R01DA053202-01A1 · under PAR-19-368 | SUSUKIDA, RYOKO | JOHNS HOPKINS UNIVERSITY, MD | $286,563 | BGES |
| 2021 | MOUD Comparative Effectiveness Study1R01DA054268-01 · under PAR-19-368 | LAROCHELLE, MARC | BOSTON MEDICAL CENTER, MA | $602,367 | HSQE |
| 2021 | Elucidating Mechanisms of Pregnancy's Protective Effect on Drug Abuse Using Integrated Data Analysis1R01DA050700-01A1 · under PAR-19-368 | MASSEY, SUENA HUANG | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $601,811 | PDRP |
| 2021 | Intersectional Approaches to Population-Level Health Research: Role of HIV Risk and Mental Health in Alcohol Use Disparities among Diverse Sexual Minority Youth1R01AA029044-01A1 · under PAR-19-368 | PHILLIPS, GREGORY L. | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $588,270 | ZRG1 |
| 2021 | Spatio-temporal Methods for Surveillance of the Opioid Syndemic1R01DA052214-01A1 · under PAR-19-368 | HEPLER, STACIKLINE, DAVID M | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $387,459 | PPAH |
| 2020 | The Epidemiology of the Weiss Cohort Project1R01DA050495-01 · under PAR-18-062 | WEISS, STANLEY H | RBHS-NEW JERSEY MEDICAL SCHOOL, NJ | $779,861 | ZRG1 |
| 2020 | The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy1R01DA049822-01 · under PAR-18-062 | BATEMAN, BRIAN THOMASHUYBRECHTS, KRISTA F | BRIGHAM AND WOMEN'S HOSPITAL, MA | $737,855 | ZRG1 |
| 2020 | Estimating the population size of persons who inject drugs in New York1R01DA051302-01 · under PAR-18-062 | BRADLEY, HEATHERROSENBERG, ELI SAMUEL | GEORGIA STATE UNIVERSITY, GA | $666,970 | ZRG1 |
| 2020 | Opioid Policy Model1R01DA047994-01A1 · under PAR-18-062 | BOBASHEV, GEORGIY | RESEARCH TRIANGLE INSTITUTE, NC | $654,553 | ZRG1 |
| 2020 | Identifying blood-based DNA methylation biomarkers of cannabis use1R01DA048824-01A1 · under PAR-18-062 | FANG, FANG | RESEARCH TRIANGLE INSTITUTE, NC | $583,308 | ZRG1 |
| 2020 | Impact of in utero Marijuana Exposure on Neurodevelopment, Behavior and Mental Health: A Longitudinal Birth Cohort Study1R01DA048033-01A1 · under PAR-18-062 | AVALOS, LYNDSAY AMMONYOUNG-WOLFF, KELLY CORINNE | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $581,449 | ZRG1 |
| 2020 | Depressive Symptoms and Tobacco Use Trajectories and Transitions across Young Adulthood1R01CA249883-01A1 · under PAR-18-062 | LOUKAS, ALEXANDRA | UNIVERSITY OF TEXAS AT AUSTIN, TX | $399,623 | ZRG1 |
| 2020 | Increasing access to medication-assisted treatment: Interactions between federal and state workforce policies1R01DA047379-01A1 · under PAR-18-062 | SPETZ, JOANNE E. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $362,812 | ZRG1 |
| 2020 | Substance Use among Biracial Adolescents and Emerging Adults: The Double Jeopardy Hypothesis1R01DA051578-01 · under PAR-19-368 | GOINGS, TRENETTE CLARK | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $346,334 | SSPB |
| 2020 | Decoding the dynamic representation of reward predictions across mesocorticostriatal circuits during learning1R01DA050647-01 · under PAR-18-062 | NIV, YAEL | PRINCETON UNIVERSITY, NJ | $283,500 | ZRG1 |
| 2019 | Telemedicine for Treatment of Opioid Use Disorder1R01DA048533-01A1 · under PAR-18-062 | HUSKAMP, HAIDEN A.MEHROTRA, ATEEV | HARVARD MEDICAL SCHOOL, MA | $735,192 | ZRG1 |
| 2019 | Maternal Marijuana Use During Pregnancy, Marijuana Legalization, and Adverse Obstetrical and Neonatal Outcomes: A 12-year Cohort Study1R01DA047405-01A1 · under PAR-18-062 | AVALOS, LYNDSAY AMMONYOUNG-WOLFF, KELLY CORINNE | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $662,872 | ZRG1 |
| 2019 | Diagnostic and prognostic biomarkers for subtypes of addiction-related circuit dysfunction1R01DA047851-01A1 · under PAR-18-062 | GOLDSTEIN, RITA ZLISTON, CONOR M | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $621,348 | ZRG1 |
| 2019 | A decentralized macro and micro gene-by-environment interaction analysis of substance use behavior and its brain biomarkers1R01DA049238-01 · under PAR-18-062 | CALHOUN, VINCE DLIU, JINGYUSCHUMANN, GUNTER | GEORGIA STATE UNIVERSITY, GA | $551,746 | ZRG1 |
| 2019 | The Etiology of Risk: Alcohol and Drug Use Disorders and Suicidal Behavior1R01AA027522-01 · under PAR-18-062 | EDWARDS, ALEXIS CSUNDQUIST, KRISTINA | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $495,786 | ZRG1 |
| 2019 | Connectome-based prediction and neurodevelopmental trajectories of alcohol phenotypes across development1R01AA027553-01 · under PAR-18-062 | SCHEINOST, DUSTINYIP, SARAH | YALE UNIVERSITY, CT | $463,176 | ZRG1 |
| 2019 | Estimating the Effect of 24/7 Sobriety on Morbidity and Mortality in North Dakota1R01AA026457-01A1 · under PAR-18-062 | NICOSIA, NANCY | RAND CORPORATION, CA | $423,173 | ZRG1 |
| 2019 | Maternal use of prescribed opioid analgesics and risk of adverse offspring outcomes1R01DA048042-01 · under PAR-18-062 | D'ONOFRIO, BRIAN MOBERG, ANNA SARA | TRUSTEES OF INDIANA UNIVERSITY, IN | $423,021 | ZRG1 |
| 2019 | Alcohol Consumption and Cardiovascular Health Among Older Couples: The Roles of Genetics and Marital Quality1R01AA026687-01A1 · under PAR-18-062 | BIRDITT, KIRA S | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $411,863 | ZRG1 |
| 2019 | As adolescent substance use declines, internalizing symptoms increase: identifying high-risk substance using groups and the role of social media, parental supervision, and unsupervised time1R01DA048853-01 · under PAR-18-062 | KEYES, KATHERINE M. | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $403,284 | ZRG1 |
| 2019 | Disrupting Pathways from Early Adversity to Adult Substance Abuse: Identifying Education Resilience Factors in Diverse Groups1R01AA026956-01A1 · under PAR-18-062 | MULIA, NINA | PUBLIC HEALTH INSTITUTE, CA | $360,675 | ZRG1 |
| 2019 | Trajectories of Nonmedical Prescription Drug Misuse2R01DA031160-07 · under PAR-18-062 | MCCABE, SEAN ESTEBAN | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $358,800 | ZRG1 |
| 2018 | Researching Effective Strategies to Prevent Opioid Death (RESPOND)1R01DA046527-01 · under PAR-16-234 | LINAS, BENJAMIN P. | BOSTON MEDICAL CENTER, MA | $788,879 | ZRG1 |
| 2018 | Developing the evidence base for overdose policies: a multilevel analysis of NHBS1R01DA046197-01 · under PAR-16-234 | COOPER, HANNAH LF | EMORY UNIVERSITY, GA | $706,993 | ZRG1 |
| 2018 | ENIGMA- Addiction: Pooling of Existing Datasets to Identify Brain and Genetic Correlates of Addiction1R01DA047119-01 · under PAR-16-234 | CONROD, PATRICIAGARAVAN, HUGH P. | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $669,057 | ZRG1 |
| 2018 | Impact of Jail-Based Methadone on Overdose, Recidivism, HIV and Health Outcomes, and Costs in New York City, 2011-20171R01DA045042-01A1 · under PAR-16-234 | LEE, JOSHUA DLIM, SUNGWOOMACDONALD, ROSS | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $666,787 | ZRG1 |
| 2018 | Identifying Opioid Overdose Predictors using EHRs1R01DA045816-01 · under PAR-16-234 | BECKER, WILLIAM CLI, WENJUNYU, HONG | UNIVERSITY OF MASSACHUSETTS LOWELL, MA | $649,552 | ZRG1 |
| 2018 | Availability, accessibility, and structure of opioid use disorder treatment and maternal and child health outcomes1R01DA045675-01A1 · under PAR-16-234 | JARLENSKI, MARIAN PATRICIAKRANS, ELIZABETH E | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $601,948 | ZRG1 |
| 2018 | Computational and Neural Modeling of Cue Reactivity in Addiction1R01DA043695-01A1 · under PAR-16-234 | GU, XIAOSI | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $561,045 | ZRG1 |
| 2018 | Missing Data Matters: Substance Use Disorder Clinical Trials1R01DA046534-01 · under PAR-16-234 | SCHARFSTEIN, DANIEL OSCAR | JOHNS HOPKINS UNIVERSITY, MD | $543,369 | ZRG1 |
| 2018 | EpiCenter ? EPIdemiology of opioid prescribing in community health CENTERs1R01DA046468-01 · under PAR-16-234 | MUENCH, JOHN | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $524,707 | ZRG1 |
| 2018 | Estimating Mediation and Moderation Effects in HIV Incidence Prevention Trials1R01DA042666-01A1 · under PAR-16-234 | PITPITAN, EILEEN VIRTUSIO | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $514,112 | ZRG1 |
| 2018 | Using a Novel Comprehensive Linked Dataset to Determine Early Predictors of Opioid Overdose1R01DA044167-01A1 · under PAR-16-234 | WEINER, SCOTT GORDON | BRIGHAM AND WOMEN'S HOSPITAL, MA | $500,872 | ZRG1 |
| 2018 | MRI data fusion to investigate effects of drug abuse on HIV neurological complications1R01DA045565-01A1 · under PAR-16-234 | MEADE, CHRISTINA S | DUKE UNIVERSITY, NC | $412,771 | ZRG1 |
| 2018 | Integrative Prioritization of Alcohol and Drug-Addiction Related Genetic Loci1R01DA042742-01A1 · under PAR-16-234 | PALMER, ROHAN HUGH CRAIG | EMORY UNIVERSITY, GA | $298,047 | ZRG1 |
| 2018 | Prospective Examination of E-Cigarette Use, Tobacco Use Disorder and Health Consequences by U.S. Youth1R01DA044157-01A1 · under PAR-16-234 | BOYD, CAROL J | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $234,000 | ZRG1 |
| 2017 | Stop-and-Frisk, Arrest, and Incarceration and STI/HIV Risk in Minority MSM1R01DA044037-01A1 · under PAR-16-234 | KHAN, MARIA RABIA | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $759,749 | ZRG1 |
| 2017 | Meta-Analysis and Machine Learning: Towards Neuromarkers of Craving and Relapse1R01DA043690-01 · under PAR-16-234 | KOBER, HEDY | YALE UNIVERSITY, CT | $450,712 | ZRG1 |
| 2017 | Discrimination, Stress and Substance Use Disorder among Sexual Minority Adults: A Secondary Analysis of NESARC-III1R01DA043696-01A1 · under PAR-16-234 | BOYD, CAROL J | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $349,125 | ZRG1 |
| 2017 | Selection and Heterogeneity in the Effects of Alcohol Policies: Insights from a Natural Experiment1R01AA025622-01 · under PAR-16-234 | NICOSIA, NANCY | RAND CORPORATION, CA | $339,904 | ZRG1 |
| 2017 | Gender and Developmental Trajectories to Adolescent Substance Use and Sexual Risk Behavior1R01DA042747-01A1 · under PAR-16-234 | MIN, MEEYOUNG OH | CASE WESTERN RESERVE UNIVERSITY, OH | $296,001 | ZRG1 |
| 2017 | How drugs, crime and criminal justice involvement influence the lives and deaths of an urban African American cohort followed for 45 years1R01DA042748-01 · under PAR-13-080 | GREEN, KERRY M | UNIV OF MARYLAND, COLLEGE PARK, MD | $224,403 | ZRG1 |
| 2017 | Neuroimaging meta-analytics for addiction: Nodes, networks,and new heuristics1R01DA041353-01A1 · under PAR-13-080 | LAIRD, ANGELA RSUTHERLAND, MATTHEW T | FLORIDA INTERNATIONAL UNIVERSITY, FL | $215,214 | ZRG1 |
| 2017 | Diagnostic and prognostic methylation biomarkers for alcohol and related health risks1R01AA026057-01 · under PAR-16-234 | CLARK, SHAUNNA L | MICHIGAN STATE UNIVERSITY, MI | $209,250 | ZRG1 |
| 2017 | Prescription Drug Misuse Characteristics in Adolescents and Young Adults: Influence of School Enrollment1R01DA043691-01 · under PAR-16-234 | SCHEPIS, TY STEPHEN | TEXAS STATE UNIVERSITY, TX | $206,810 | ZRG1 |
| 2017 | Using existing data to understand and ameliorate risk in opioid agonist therapy1R01DA044170-01 · under PAR-16-234 | DEGENHARDT, LOUISA | UNIVERSITY OF NEW SOUTH WALES | $197,214 | ZRG1 |
| 2016 | A Model Averaging Approach to Causal Inference in Substance Abuse Prevention Research1R01DA040721-01A1 · under PAR-13-080 | HAN, BING | RAND CORPORATION, CA | $285,381 | ZRG1 |
| 2016 | Understanding the Beliefs, Concerns, and Needs of Pregnant Patients Who Use Marijuana and of the Obstetrics Providers Caring for Them1R56DA040617-01 · under PAR-13-080 | CHANG, JUDY C | MAGEE-WOMEN'S RES INST AND FOUNDATION, PA | $285,125 | ZRG1 |
| 2016 | The Impact of State Healthcare Reforms on Treatment of Substance Use Disorders1R01DA039863-01A1 · under PAR-13-080 | CRUM, ROSA M.MOJTABAI, RAMIN | JOHNS HOPKINS UNIVERSITY, MD | $255,581 | ZRG1 |
| 2016 | Functional networks related to cocaine dependence and its treatment and relapse1R01DA039136-01A1 · under PAR-13-080 | XU, JIANSONG | YALE UNIVERSITY, CT | $251,000 | ZRG1 |
| 2016 | Non-Medical Use of Prescription Opioids Among HIV-Infected Individuals: Trajectories and Impact on Health Outcomes1R01DA040471-01A1 · under PAR-13-080 | EDELMAN, E. JENNIFER | YALE UNIVERSITY, CT | $238,688 | ZRG1 |
| 2016 | The Intergeneration Effects of Criminal Justice Policies on Substance Use Crimes1R01DA040726-01A1 · under PAR-13-080 | ELDRED KOZECKE, LINDSEYGIFFORD, ELIZABETH JOANNESLOAN, FRANK A | DUKE UNIVERSITY, NC | $238,500 | ZRG1 |
| 2016 | Multilevel Moderators of Drugs, Violence, Poverty and HIV Among Black Youth and Young Adults Living in Baltimore2R01DA032550-04 · under PAR-13-080 | REBOUSSIN, BETH A. | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $236,797 | ZRG1 |
| 2016 | SMOKING, SUICIDE AND MENTAL HEALTH: USING POLICY CHANGE TO PROBE CAUSALITY1R01DA042195-01 · under PAR-13-080 | GRUCZA, RICHARD A | WASHINGTON UNIVERSITY, MO | $228,925 | ZRG1 |
| 2016 | Opioid Prescribing in Medicaid: Healthcare Utilization and Deaths from Overdose1R01DA039930-01A1 · under PAR-13-080 | JAYAWARDHANA, JAYANIPERRI, MATTHEW | UNIVERSITY OF GEORGIA, GA | $225,000 | ZRG1 |
| 2016 | E-Cigarette Use and Longitudinal Changes in Cigarette Smoking and Health1R01CA203809-01 · under PAR-13-080 | MCCABE, SEAN ESTEBAN | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $217,388 | ZRG1 |
| 2016 | The Long-term Costs and Benefits of Alcohol Treatments1R01AA024423-01A1 · under PAR-13-080 | BARBOSA, CAROLINA | RESEARCH TRIANGLE INSTITUTE, NC | $215,283 | ZRG1 |
| 2015 | Detection, Understanding and Reduction of Latino Health Care Disparities1R01DA038608-01A1 · under PAR-13-080 | GARNER, BRYAN RGUERRERO, ERICK | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $252,870 | ZRG1 |
| 2015 | Genes, Environment and Drug Use in Three Baltimore Cohorts1R01DA036525-01A1 · under PAR-13-080 | MAHER, BRION S | JOHNS HOPKINS UNIVERSITY, MD | $243,000 | ZRG1 |
| 2015 | Trajectories of Nonmedical Prescription Drug Misuse2R01DA031160-04 · under PAR-13-080 | MCCABE, SEAN ESTEBAN | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $232,500 | ZRG1 |
| 2015 | ADHD and Substance Problems in Adolescence: Specificity, Mechanisms, and Gender1R01DA038065-01A1 · under PAR-13-080 | ELKINS, IRENE J | UNIVERSITY OF MINNESOTA, MN | $228,000 | ZRG1 |
| 2015 | Age-Varying Effects in the Epidemiology of Drug Abuse1R01DA039854-01 · under PAR-13-080 | LANZA, STEPHANIE T | PENNSYLVANIA STATE UNIVERSITY, THE, PA | $226,050 | ZRG1 |
| 2015 | Borderline Personality and Inmates' Post-release Substance Abuse and HIV Risk Behavior1R01DA038128-01A1 · under PAR-13-080 | TANGNEY, JUNE P | GEORGE MASON UNIVERSITY, VA | $193,800 | ZRG1 |
| 2014 | Role of Childhood Cumulative Risk in Substance Misuse and Co-occurring Problems1R01DA038450-01 · under PAR-13-080 | MASON, W ALEXSAVOLAINEN, JUKKA K | FATHER FLANAGAN'S BOYS' HOME, NE | $255,393 | ZRG1 |
| 2014 | A Network Analytic Model of Adherence and Abstinence1R01DA035775-01A1 · under PAR-13-080 | BERNSTEIN, STEVEN L | YALE UNIVERSITY, CT | $247,461 | ZRG1 |
| 2014 | Generalizing RCT Efficacy Evidence: Application to NIDA Clinical Trials Network1R01DA036520-01 · under PAR-13-080 | MOJTABAI, RAMIN | JOHNS HOPKINS UNIVERSITY, MD | $243,000 | ZRG1 |
| 2014 | Imaging data re-analysis for cocaine addiction1R56DA036556-01A1 · under PAR-13-080 | WANG, ZE | UNIVERSITY OF PENNSYLVANIA, PA | $240,000 | ZRG1 |
| 2014 | Early Substance Use in Rural American Indian and White/Anglo Youth1R01DA036523-01A1 · under PAR-13-080 | SHANAHAN, LILLY | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $239,304 | ZRG1 |
| 2014 | Multi-modal MRI data fusion to assess neurobiological effects of marijuana use1R01DA037265-01 · under PAR-13-080 | NICKERSON, LISA D | MCLEAN HOSPITAL, MA | $237,000 | ZRG1 |
| 2014 | Peer Mechanisms in the Internalizing Pathway to Substance Use1R01DA037215-01 · under PAR-13-080 | HUSSONG, ANDREA M | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $232,576 | ZRG1 |
| 2014 | Maternal Age, Trajectories of Substance Use, and Health Disparities1R01DA037209-01 · under PAR-13-080 | DE GENNA, NATACHA | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $231,000 | ZRG1 |
| 2014 | Causal Inferences for treatment moderators on Zero-Inflated outcomes of HIV risk1R01DA036557-01A1 · under PAR-13-080 | GALLOP, ROBERT | UNIVERSITY OF PENNSYLVANIA, PA | $148,800 | ZRG1 |
| 2014 | Longitudinal Study of Trauma, HIV Risk, and Criminal Justice Involvement1R01DA036414-01A1 · under PAR-13-080 | KHAN, MARIA RABIA | UNIVERSITY OF FLORIDA, FL | $53,557 | BSPH |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.